Patients who continue with treatment and implement recommended lifestyle adjustments can achieve considerable weight loss over a period of 6 to 12 months or more
My team and I set out to test whether GLP-1 drugs medications like semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound), originally developed for diabetes and then approved for obesity could do what no existing addiction treatment does: curb craving itself
LY3437943, a Novel Triple Glucagon, GIP, and GLP-1 Receptor Agonist for Glycemic Control and Weight Loss: From Discovery to Clinical Proof of Concept
Keep Your GLP-1s Safe and Treatment On Track At first, all the storage rules and temperature ranges can feel a bit overwhelming, but once you get familiar with your prescription's specific instructions, it quickly becomes second nature
That said, its not a one-size-fits-all solution
Proper use and dosage instructions must be strictly followed to reduce negative effects and increase efficacy